Benefit of Continuous Glucose Monitoring (CGM) in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes
Miller KM, Kanapka LG, Rickels M, et al.
Diabetes Technol Ther. Pub. online 16 March 2022.
Leggi
Breaking news
Longitudinal association of depressive symptoms, binge eating, and quality of life with cardiovascular risk factors in young adults with youth-onset type 2 diabetes: the TODAY2 study
TODAY Study Group
Diabetes Care. 2022;dc211995.
Leggi
Linea Guida della Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID) e della Società Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP)
La terapia del diabete mellito di tipo 1
Leggi
GLP-1RAs for ischemic stroke prevention in patients with type 2 diabetes without established atherosclerotic cardiovascular
Yang YS, Chen HH, Huang CN, et al.
Diabetes Care. 2022;dc211285
Leggi
When therapeutic drugs lead to diabetes
Fève B, Scheen AJ
Diabetologia. Pub. online 4 March 2022.
Leggi
Which scale is more useful to detect diabetic neuropathic pain? A cross-sectional study
Ünlütürk Z, Öztekin SNS, Alkan H, et al.
BMC Endocr Disord. 2022;22(1):56.
Leggi
Clinical insights into management options for recurrent type 2 diabetes and cardiovascular risk after metabolic-bariatric surgery
Lupoli R, Lembo E, Giosuè A, et al.
NMCD. Pub. online 9 March 2022.
Leggi
Association between real-time continuous glucose monitor use and diabetes-related medical costs for patients with type 2 diabetes
Norman G, Paudel ML, Parkin CG, et al.
Diabetes Technol Ther. Pub. online 1 Mar 2022.
Leggi
Feasibility of closed-loop insulin delivery with a pregnancy specific zone model predictive control algorithm
Ozaslan B, Levy C, Kudva YC, et al.
Diabetes Technol Ther. Pub. online 1 Mar 2022.
Leggi
Clinical outcomes with metformin and sulfonylurea therapies among patients with heart failure and diabetes
Khan MS, Solomon N, DeVore AD, et al.
JACC Heart Fail. 2022;10(3):198-210.
Leggi